By InvitationNot Applicable

Clinical Decision Support With Continuous Glucose Monitoring Data for Managing Type 2 Diabetes

United States150 participantsStarted 2026-03-04

Plain-language summary

The goal of this project is to see if an electronic health record (EHR)-based smart order set with continuous glucose monitoring data to provide decision support can improve blood sugar management in people with type 2 diabetes (T2D) using insulin.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Type 2 diabetes * A1c greater than 7.5% * On insulin therapy * Use CGM for glycemic monitoring Exclusion Criteria: * Pregnancy * Use of insulin pump or automated insulin delivery system * Active cancer (other than nonmelanoma skin cancer or low-grade prostate cancer being followed with observation) * Cognitive barriers requiring assistance of a surrogate or caregiver for insulin management

What they're measuring

Change in % glucose management indicator (GMI%)

Timeframe: Baseline and 6 months

Trial details

NCT IDNCT07394075

SponsorHealthPartners Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-03

View on ClinicalTrials.gov More Type 2 Diabetes trials